A. D. Duru Et Al. , "Multiple Myeloma patients with del(8)(p21) are more resistant to Bortezomib treatment," 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , İstanbul, Turkey, 2015
Duru, A. D. Et Al. 2015. Multiple Myeloma patients with del(8)(p21) are more resistant to Bortezomib treatment. 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , (İstanbul, Turkey).
Duru, A. D., Sutlu, T., Wallblom, A., Uttervall, K., Lund, J., Stellan, B., ... Gahrton, G.(2015). Multiple Myeloma patients with del(8)(p21) are more resistant to Bortezomib treatment . 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey
Duru, A. Et Al. "Multiple Myeloma patients with del(8)(p21) are more resistant to Bortezomib treatment," 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 2015
Duru, A. D. Et Al. "Multiple Myeloma patients with del(8)(p21) are more resistant to Bortezomib treatment." 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , İstanbul, Turkey, 2015
Duru, A. D. Et Al. (2015) . "Multiple Myeloma patients with del(8)(p21) are more resistant to Bortezomib treatment." 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={A. D. Duru Et Al. }, title={Multiple Myeloma patients with del(8)(p21) are more resistant to Bortezomib treatment}, congress name={41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation}, city={İstanbul}, country={Turkey}, year={2015}}